Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ryoji Hirose"'
Autor:
Emiko Takeishi, Ryoji Hirose
Publikováno v:
Skin Cancer. 31:238-243
Autor:
Ryoji Hirose, Yoshiyuki Kamio
Publikováno v:
Nishi Nihon Hifuka. 75:313-316
Publikováno v:
Skin Cancer. 28:39-45
Autor:
Emiko Takeishi, Ryoji Hirose
Publikováno v:
Skin Cancer. 27:37-42
Publikováno v:
Biological and Pharmaceutical Bulletin. 35:1349-1353
We investigated the structure-activity relationship between various ISP-I (myriocin, thermozymocidin) analogous which has sphingosine-like structure and serine palmitoyltransferase (SPT) in Chinese hamster ovary (CHO) cells utilizing sphingolipid pro
Publikováno v:
Skin Cancer. 25:85-89
Autor:
Fumihide Ogawa, Yutaka Kuwatsuka, Yuichiro Akiyama, Kazuhiro Komura, Toshiyuki Aki, Ryoji Hirose, Saori Tomimura, Hiroaki Ida, Shinichi Sato, Motoi Takenaka
Publikováno v:
Nishi Nihon Hifuka. 70:371-376
2005年から2006年にかけて,当科では若年性全身性強皮症3例を経験した。症例1:15歳,女性。初診の4ヵ月前よりレイノー症状が出現,1ヵ月前より両手指と両手背の皮膚硬化を伴ったため当
Publikováno v:
Skin Cancer. 22:77-80
66歳男性が右足底の15×22mmの黒色斑を主訴に受診した。左右非対称性, 辺縁不整, 色調は一様であるが濃黒色を呈した。表在リンパ節の腫大はなかった。臨床所見から悪性黒色腫と診断し
Autor:
Takeyuki Kohno, Norimasa Matsumoto, Wasako Kurio, Shoji Yamaguchi, Haruko Kusumoto, Takaaki Shimizu, Kazuhito Watabe, Kazuo Yanada, Shuji Uchida, Tetsuro Fujita, Ryoji Hirose
Publikováno v:
Bioorganic & Medicinal Chemistry. 14:4182-4192
FTY720 ( 1 ) is a novel immunosuppressant (immunomodulator), derived from ISP-I ( 2 : myriocin and thermozymocidin). To clarify the pharmacokinetic properties of 1 , antibodies against 1 were prepared and a competitive enzyme immunoassay (EIA) was de
Publikováno v:
Skin Cancer. 21:376-379